癌症免疫治疗患者报告结局量表的研究进展及护理启示

doi:10.3761/j.issn.0254-1769.2026.03.018

中华护理杂志 ›› 2026, Vol. 61 ›› Issue (3): 419-426.DOI: 10.3761/j.issn.0254-1769.2026.03.018

癌症免疫治疗患者报告结局量表的研究进展及护理启示

张德发¹(), 王倩²^,^*(), 金玉芹³, 闫荣⁴, 毛会清⁵, 徐萍⁶, 张淼淼⁷

1.山东第一医科大学护理学院济南市 250117
2.山东第一医科大学附属肿瘤医院卵巢肿瘤病区济南市 250021
3.山东第一医科大学附属肿瘤医院影像科济南市 250021
4.山东第一医科大学附属肿瘤医院预防管理部济南市 250021
5.山东第一医科大学附属肿瘤医院呼吸内科二病区济南市 250021
6.潍坊市精神卫生中心精神一科女病区潍坊市 261000
7.泰山护理职业学院健康管理系泰安市 271000

收稿日期:2025-09-10 出版日期:2026-02-10 发布日期:2026-02-03
*通讯作者: 王倩，E-mail：568544668@qq.com
作者简介:张德发：男，本科（硕士在读），E-mail：defa_0127@163.com

Research progress and nursing enlightenment of patient-reported outcome measures for cancer immuno-therapy

ZHANG Defa¹(), WANG Qian²^,^*(), JIN Yuqin³, YAN Rong⁴, MAO Huiqing⁵, XU Ping⁶, ZHANG Miaomiao⁷

1. School of Nursing，Shandong First Medical University，Jinan 250117，China
2. Ovarian Oncology Ward，Cancer Hospital of Shandong First Medical University，Jinan 250021，China
3. Department of Radiology，Cancer Hospital of Shandong First Medical University，Jinan 250021，China
4. Department of Prevention Management，Cancer Hospital of Shandong First Medical University，Jinan 250021，China
5. Ward 2，Department of Respiratory Medicine，Cancer Hospital of Shandong First Medical University，Jinan 250021，China
6. Female Ward，the First Department of Psychiatry，Weifang Mental Health Center，Weifang 261000，China
7. Department of Health Management，Taishan Vocational College of Nursing，Taian 271000，China

Received:2025-09-10 Online:2026-02-10 Published:2026-02-03
* Corresponding author: WANG Qian，E-mail：568544668@qq.com

摘要/Abstract

摘要：

随着免疫治疗在癌症患者中的广泛应用，免疫相关不良事件已成为临床关注的重点。准确评估这些不良反应及其对患者健康相关生活质量的影响，是癌症免疫治疗中不可忽视的一部分。该文对患者报告结局进行概述，并从普适性和特异性2个方面汇总现有的癌症免疫治疗患者报告结局量表，重点梳理并比较了现有工具的内容特点、不足及临床应用情况。在此基础上，提出未来发展方向，以便为癌症免疫治疗特异性评估工具的优化开发、临床转化应用及护理实践提供参考依据。

关键词: 癌症, 免疫治疗, 患者报告结局量表, 综述, 护理

Abstract:

With the widespread application of immunotherapy in cancer patients，immune-related adverse events have become a key focus of clinical attention. Accurately assessing these adverse reactions and their impact on patients’ health-related quality of life is an indispensable part of cancer immunotherapy. This article reviews the research progress of patient-reported outcomes，and summarizes the existing patient reported outcomes scale for cancer immunotherapy from two aspects of universality and specificity，with a focus on summarizing and comparing the content characteristics，limitations，and clinical application of existing tools. Building on this，it proposes future development directions to provide a reference for the optimal development，clinical translation，and nursing practice concerning these cancer immunotherapy-specific assessment tools.

Key words: Cancer, Immunotherapy, Patient-Reported Outcomes Measures, Review, Nursing Care

张德发, 王倩, 金玉芹, 闫荣, 毛会清, 徐萍, 张淼淼. 癌症免疫治疗患者报告结局量表的研究进展及护理启示[J]. 中华护理杂志, 2026, 61(3): 419-426.

ZHANG Defa, WANG Qian, JIN Yuqin, YAN Rong, MAO Huiqing, XU Ping, ZHANG Miaomiao. Research progress and nursing enlightenment of patient-reported outcome measures for cancer immuno-therapy[J]. Chinese Journal of Nursing, 2026, 61(3): 419-426.

参考文献 34

[1]	Ghemrawi R, Abuamer L, Kremesh S, et al. Revolutionizing can-cer treatment:recent advances in immunotherapy[J]. Biomedici-nes, 2024, 12(9):2158.
[2]	Neil VM, Lee SW. Advancing cancer treatment:a review of im-mune checkpoint inhibitors and combination strategies[J]. Can-cers, 2025, 17(9):1408.
[3]	Schneider BJ, Naidoo J, Santomasso BD, et al. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy:ASCO guideline update[J]. J Clin Oncol, 2021, 39(36):4073-4126. DOI URL
[4]	Zhang XM, Zhu LL, Zhang H, et al. CAR-T cell therapy in he-matological malignancies:current opportunities and challenges[J]. Front Immunol, 2022,13:927153.
[5]	Hsiehchen D, Watters MK, Lu R, et al. Variation in the asses-sment of immune-related adverse event occurrence,grade,and timing in patients receiving immune checkpoint inhibitors[J]. JAMA Netw Open, 2019, 2(9):e1911519. DOI URL
[6]	Liu YH, Zang XY, Wang JC, et al. Diagnosis and management of immune related adverse events(irAEs) in cancer immuno-therapy[J]. Biomed Pharmacother, 2019,120:109437.
[7]	Jennifer Wang S, Dougan SK, Dougan M. Immune mechanisms of toxicity from checkpoint inhibitors[J]. Trends Cancer, 2023, 9(7):543-553. DOI PMID
[8]	Lai-Kwon J, Thorner E, Rutherford C, et al. Integrating patient-reported outcomes into the care of people with advanced cancer-a practical guide[J]. Am Soc Clin Oncol Educ Book, 2024, 44(3):e438512. DOI URL
[9]	Department of Health and Human Services FDA Center for Drug Evaluation and Research US,Department of Health and Human Services FDA Center for Biologics Evaluation and Research US, Department of Health and Human Services FDA Center for Devices and Radiological Health US. Guidance for industry:patient-reported outcome measures:use in medical product development to support labeling claims:draft guidance[J]. Health Qual Life Outcomes, 2006,4:79.
[10]	Colomer-Lahiguera S, Bryant-Lukosius D, Rietkoetter S, et al. Patient-reported outcome instruments used in immune-check-point inhibitor clinical trials in oncology:a systematic review[J]. J Patient Rep Outcomes, 2020, 4(1):58. DOI PMID
[11]	Churruca K, Pomare C, Ellis LA, et al. Patient-reported outcome measures(PROMs):a review of generic and condition-specific measures and a discussion of trends and issues[J]. Health Ex-pect, 2021, 24(4):1015-1024.
[12]	吴傅蕾, 刘欢, 袁长蓉. 患者报告结局在肿瘤照护领域的应用现状及思考[J]. 解放军护理杂志, 2017, 34(3):47-50.
	Wu FL, Liu H, Yuan CR. Application status and thinking of patient report outcome in cancer care field[J]. Nurs J Chin PLA, 2017, 34(3):47-50.
[13]	孟祥敏, 王倩, 闫荣, 等. 结直肠癌患者报告结局评估工具及临床应用的研究进展[J]. 中华护理杂志, 2022, 57(9):1094-1099. DOI
	Meng XM, Wang Q, Yan R, et al. Research progress on assessment tools of patient-reported outcomes for colorectal cancer patients and the clinical application[J]. Chin J Nurs, 2022, 57(9):1094-1099. DOI
[14]	张柳媛, 孙尔维, 陈嘉盈, 等. 系统性红斑狼疮特异性患者报告结局评估工具的研究进展[J]. 护士进修杂志, 2025, 40(18):1961-1965.
	Zhang LY, Sun EW, Chen JY, et al. Research progress on spe-cific patient-reported outcomes assessment tools for patients with systemic lupus erythematosus[J]. J Nurses Train, 2025, 40(18):1961-1965.
[15]	Hansen AR, Ala-Leppilampi K, McKillop C, et al. Development of the Functional Assessment of Cancer Therapy-Immune Check-Point Modulator(FACT-ICM):a toxicity subscale to measure quality of life in patients with cancer who are treated with ICMs[J]. Cancer, 2020, 126(7):1550-1558. DOI PMID
[16]	Meng XM, Shang MM, Wang Q, et al. Reliability and validity of the simplified Chinese version of the Functional Assessment of Cancer Therapy-Immune Check-Point Modulator[J]. Qual Life Res, 2023, 32(6):1581-1593. DOI
[17]	Bergerot PG, Bergerot CD, Silva JRG, et al. Exercising and im-muno-oncology treatment(ExIO):a Prospective pilot study for patients with solid tumors[J]. Support Care Cancer, 2024, 32(12):840. DOI PMID
[18]	Lu RQ, Yang ZH, Miao JX, et al. Latent profile analysis of self-management and its association with quality of life differen-ces in patients with cancer treated with immune checkpoint inhibitors[J]. Asia Pac J Oncol Nurs, 2025,12:100687.
[19]	Mendoza T, Sheshadri A, Altan M, et al. Evaluating the psy-chometric properties of the immunotherapy module of the MD Anderson symptom inventory[J]. J Immunother Cancer, 2020, 8(2):e000931. DOI URL
[20]	Wu XD, Xie JY, Lin XM, et al. Translation and validation of Chinese version of MDASI immunotherapy for early-phase trials module:a cross-sectional study[J]. BMC Nurs, 2023, 22(1):176. DOI
[21]	Mendoza TR, Hong DS, Peterson CB, et al. Patient-reported sym-ptom burden in patients with rare cancers receiving pembro-lizumab in a phase II clinical trial[J]. Sci Rep, 2022, 12(1):14367. DOI PMID
[22]	贺瑾, 冯丽娜, 李艳. 肿瘤免疫检查点抑制剂治疗症状评估量表的编制及信效度检验[J]. 中国实用护理杂志, 2023, 39(7):481-485.
	He J, Feng LN, Li Y, et al. Establishment and reliablity and validity test of the Symptom Assessment Scale for Patients Treated with Tumor Immune Checkpoint Inhibitors[J]. Chin J Pract Nurs, 2023, 39(7):481-485.
[23]	李宁, 张勇, 贾江坤. 恶性黑色素瘤患者接受免疫检查点抑制剂治疗相关症状群及影响因素[J]. 军事护理, 2024, 41(11):65-69.
	Li N, Zhang Y, Jia JK. Analysis of symptom clusters and influencing factors in malignant melanoma patients treated with immune checkpoint inhibitors[J]. Mil Nurs, 2024, 41(11):65-69.
[24]	严浩宇. 癌症免疫治疗患者症状自我报告量表的构建[D]. 苏州: 苏州大学, 2023.
	Yan HY. Construction of Symptom Self-Report Scale for cancer immunotherapy patients[D]. Suzhou: Soochow University, 2023.
[25]	Wang XS, Srour SA, Mendoza T, et al. Development and vali-dation of a patient-reported outcome measure to assess sym-ptom burden after chimeric antigen receptor T-cell therapy[J]. Br J Haematol, 2023, 201(4):738-746. DOI URL
[26]	MD Anderson Cancer Center. MD anderson symptom invento-ry-car module[EB/OL].[2025-09-09]. https://www.mdanderson.org/research/departments-labs-institutes/departments-divisions/sy-mptom-research/symptom-assessment-tools/md-anderson-symptom-inventory-car-module.html.
[27]	毛奕文. 行CAR-T疗法淋巴瘤患者电子化自我报告结局问卷的开发及应用[D]. 武汉: 华中科技大学, 2024.
	Mao YW. Development and application of electronic Self-Report Outcome Questionnaire for Lymphoma Patients under-going CAR-T therapy[D]. Wuhan: Huazhong University of Science and Technology, 2024.
[28]	彭娜娜, 张晓菊, 陈凤珍, 等. 肺癌免疫治疗PRO-CTCAE子集的构建[J]. 护士进修杂志, 2023, 38(19):1729-1734.
	Peng NN, Zhang XJ, Chen FZ, et al. Development of a PRO-CTCAE-based subset for patients with lung cancer receiving immunotherapy[J]. J Nurses Train, 2023, 38(19):1729-1734.
[29]	彭娜娜, 陆箴琦, 王佳蕾, 等. 肺癌免疫治疗患者疲乏相关症状群变化轨迹及其影响因素[J]. 肿瘤, 2024, 44(7):693-707.
	Peng NN, Lu ZQ, Wang JL, et al. The trajectory of fatigue-related symptom clusters and influencing factors in patients with lung cancer receiving immunotherapy[J]. Tumor, 2024, 44(7):693-707.
[30]	Fan TT, Zhu SY, Wang H, et al. Development and validation of the Self-Report Symptom Inventory of Immune-Related Ad-verse Events in Patients with Lung Cancer[J]. Asia Pac J Oncol Nurs, 2024, 11(12):100603. DOI URL
[31]	伍泳欣, 刘晓华, 吴莹嘉, 等. 非小细胞肺癌免疫检查点抑制剂治疗病人症状评估量表的构建[J]. 护理研究, 2023, 37(5):826-832.
	Wu YX, Liu XH, Wu YJ, et al. Construction of Symptom Asse-ssment Scale for patients with non- small cell lung cancer treated with immune checkpoint inhibitors[J]. Chin Nurs Res, 2023, 37(5):826-832.
[32]	尚子妺, 吴静, 周洁. 乳腺癌患者睡眠及相关症状的轨迹研究[J]. 中华护理杂志, 2019, 54(10):1456-1462. DOI
	Shang ZM, Wu J, Zhou J. A trajectory study of sleep and related symptoms in breast cancer patients based on ecolo-gical momentary assessment[J]. Chin J Nurs, 2019, 54(10):1456-1462.
[33]	王晴, 黄晓婷, 唐四元, 等. 即时适配干预在护理领域中的应用进展[J]. 中华护理杂志, 2024, 59(4):490-495. DOI
	Wang Q, Huang XT, Tang SY, et al. The application progress of just-in-time adaptive intervention in nursing[J]. Chin J Nurs, 2024, 59(4):490-495. DOI
[34]	刘瑾, 白蕊, 张佩英, 等. 2种量表用于慢性伤口患者生活质量测评的对比研究[J]. 中华护理杂志, 2023, 58(5):558-564. DOI
	Liu J, Bai R, Zhang PY, et al. Comparison of 2 questionnaires in evaluating the quality of life of patients with chronic wounds[J]. Chin J Nurs, 2023, 58(5):558-564. DOI

癌症免疫治疗患者报告结局量表的研究进展及护理启示

Research progress and nursing enlightenment of patient-reported outcome measures for cancer immuno-therapy

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 34

相关文章 15

编辑推荐

Metrics

[1]	盛旭, 丛胜楠, 张娟, 凌秀凤, 朱珠, 陈声容, 赵静. 辅助生殖专科护理质量评价指标体系的构建及验证[J]. 中华护理杂志, 2026, 61(3): 293-301.
[2]	薛晶, 王喆, 成放群, 陈思宇, 贺聪, 徐强, 彭鹏, 成沛玉. 不孕症患者体外受精-胚胎移植治疗期间心理弹性变化轨迹及影响因素研究[J]. 中华护理杂志, 2026, 61(3): 302-309.
[3]	黄慧红, 刘金莲, 王子睿, 李金璐, 史莉, 杨蕊. 体外受精-胚胎移植患者取卵术后疼痛水平的影响因素及路径分析[J]. 中华护理杂志, 2026, 61(3): 310-317.
[4]	吴梅利洋, 杨柳, 杨娟, 瞿佳, 闵敏. 不孕症患者辅助生殖治疗旅程地图的绘制及护理启示[J]. 中华护理杂志, 2026, 61(3): 318-325.
[5]	黄春艳, 沈晓星, 朱海琼, 陈运, 欧阳文慧, 杨晨, 欧阳晓俊. 老年患者口腔功能锻炼方案的构建及应用效果评价[J]. 中华护理杂志, 2026, 61(3): 326-331.
[6]	巩晓珊, 林安琪, 秦玉, 王玲. 术前虚拟现实场景模拟训练对老年肺癌患者术后谵妄的干预效果研究[J]. 中华护理杂志, 2026, 61(3): 332-339.
[7]	苏穗, 童青青, 钟飞, 赵淋艺, 周满红, 李涛, 高绘明, 覃智芳, 胡汝均. 院外心搏骤停患者共享急救网络平台的开发与可用性评价[J]. 中华护理杂志, 2026, 61(3): 340-346.
[8]	刘凤春, 孟茜, 宋晓萌, 穆东帅, 王艳, 王雪, 常红. 择时穴位贴敷对帕金森病患者夜间尿频的护理效果研究[J]. 中华护理杂志, 2026, 61(3): 347-352.
[9]	宋艳如, 杜云红, 岳圆圆, 陈小杰, 吴瑞芝, 王莉. 慢性阻塞性肺疾病患者社会隔离现状及影响因素的混合研究[J]. 中华护理杂志, 2026, 61(3): 353-360.
[10]	李修平, 梁娇娇, 王玲玲, 付琴, 侯铭, 李萍. 中老年脑卒中患者及家庭照顾者家庭弹性、护理能力与衰弱间的关系研究[J]. 中华护理杂志, 2026, 61(3): 361-367.
[11]	田凤美, 李惠玲, 安清, 王金悦, 谭丽萍, 赵丽爽. 中晚期结直肠癌患者症状负担的潜在剖面及影响因素研究[J]. 中华护理杂志, 2026, 61(3): 368-376.
[12]	张世纪, 田艳珍, 李金秀, 邓力邦, 张涛. 空巢老年糖尿病患者用药偏差影响因素分析[J]. 中华护理杂志, 2026, 61(3): 377-384.
[13]	陈元元, 刘扣英, 汤婷, 屈明叶, 杨澜, 蔡昊, 王晨, 汪璐璐, 李祥硕. 国内提升患者就医体验相关政策的文本分析及护理启示[J]. 中华护理杂志, 2026, 61(3): 385-393.
[14]	连蕊, 郑福雪, 田君叶, 谭艳芬, 宋亚静, 韩宁, 李妍, 蒙景雯, 曾镇罡. 供应-加工-配送模式下低值医用耗材智能管理的研究[J]. 中华护理杂志, 2026, 61(3): 394-400.
[15]	程凤, 王贺, 王金龙, 付红. 1例产后合并高血氨脑病患者行肝移植的护理[J]. 中华护理杂志, 2026, 61(3): 401-405.